LakeShore Biopharma Co., Ltd. (LSBCF) research
LakeShore Biopharma Co., Ltd.- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $0.07
- As of
LakeShore Biopharma Co., Ltd. (LSBCF): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 6-K filed 2026-06-24.
As of . Source: SEC EDGAR filings for LSBCF. Method and limitations.
Share the LSBCF intelligence card
See the full LSBCF dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for LSBCF on one page. Preview it with sample data, then open it live with a free account.
Preview the LSBCF dossierActive signals for LSBCF
- mediumEARNINGS_MISS
Q4-2024: Missed consensus by 128.7% - EPS $-13.4 vs $-5.858 estimate
- mediumEARNINGS_MISS
Missed consensus by 128.7% - EPS $-13.4 vs $-5.858 estimate
FREE, NO ACCOUNT
Every signal on LSBCF, as it fires
New filings, 13F moves and cross asset signals on LSBCF land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.
Recent SEC filings, LSBCF
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
Related tickers
See more LSBCF signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to LSBCFand get the insider, 13F, options, and confluence read in one view.